References
Aftab BT, Dobromilskaya I, Liu JO, Rudin CM (2011) Itraconazole inhibits angiogenesis and
tumor growth in non-small cell lung cancer. Cancer Res. 71:6764–6772. https://doi.org/10.
1158/0008-5472.CAN-11-0691
Arend KC, Lenarcic EM, Vincent HA et al (2017) Kinome profiling identifies druggable targets for
novel human cytomegalovirus (HCMV) antivirals. Mol. Cell. Proteomics 16:S263–S276.
https://doi.org/10.1074/mcp.M116.065375
Belardinelli L, Harder D, Sperelakis N et al (1979) Cardiac glycoside stimulation of inward Ca++
current in vascular smooth muscle of canine coronary artery. J. Pharmacol. Exp. Ther. 209:62–
66
Bixler SL, Duplantier AJ, Bavari S (2017) Discovering drugs for the treatment of Ebola virus. Curr.
Treat. Options Infect. Dis. 9:299–317. https://doi.org/10.1007/s40506-017-0130-z
Cavalla D (2017) Scientific commercial value of drug repurposing. In: Dudley J, Berliocchi LE
(eds) Drug repositioning – approaches and applications for neurotherapeutics. Taylor & Francis
Group, Abingdon, pp 3–22
Chang WL, Hsu LC, Leu WJ et al (2015) Repurposing of nitroxoline as a potential anticancer agent
against human prostate cancer – a crucial role on AMPK/mTOR signaling pathway and the
interplay with Chk2 activation. Oncotarget 6:39806–39820. https://doi.org/10.18632/
oncotarget.5655
Droebner K, Haasbach E, Dudek SE et al (2017) Pharmacodynamics, pharmacokinetics, and
antiviral activity of BAY 81-8781, a novel NF-κB inhibiting anti-influenza drug. Front.
Microbiol. 8:2130. https://doi.org/10.3389/fmicb.2017.02130
Gardner TJ, Cohen T, Redmann V et al (2015) Development of a high-content screen for the
identification of inhibitors directed against the early steps of the cytomegalovirus infectious
cycle. Antivir. Res. 113:49–61. https://doi.org/10.1016/j.antiviral.2014.10.011
Hampson L, Maranga IO, Masinde MS et al (2016) A single-arm, proof-of-concept trial of
lopimune (lopinavir/ritonavir) as a treatment for HPV-related pre-invasive cervical disease.
PLoS One 11:e0147917. https://doi.org/10.1371/journal.pone.0147917
Hollman A (1996) Drugs for atrial fibrillation. Digoxin comes from Digitalis lanata. BMJ 312:912
Hu Y, Zhang J, Musharrafieh RG et al (2017) Discovery of dapivirine, a nonnucleoside HIV-1
reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza a and B
viruses. Antivir. Res. 145:103–113. https://doi.org/10.1016/j.antiviral.2017.07.016
Hung IFN, To KKW, Chan JFW et al (2017) Efficacy of clarithromycin-naproxen-oseltamivir
combination in the treatment of patients hospitalized for influenza a(H3N2) infection: an open-
label randomized, controlled, phase IIb/III trial. Chest 151:1069–1080. https://doi.org/10.1016/
j.chest.2016.11.012
Kapoor A, Cai H, Forman M et al (2012) Human cytomegalovirus inhibition by cardiac glycosides:
evidence for involvement of the hERG gene. Antimicrob. Agents Chemother. 56:4891–4899.
https://doi.org/10.1128/AAC.00898-12
Kepp O, Menger L, Vacchelli E et al (2012) Anticancer activity of cardiac glycosides: at the frontier
between cell-autonomous and immunological effects. Onco Targets Ther 1:1640–1642
Khuroo MS (2020) Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-
19). Facts, fiction and the hype: a critical appraisal. Int. J. Antimicrob. Agents 56:106101
Kim J, Tang JY, Gong R et al (2010) Itraconazole, a commonly used antifungal that inhibits
hedgehog pathway activity and cancer growth. Cancer Cell 17:388–399. https://doi.org/10.
1016/j.ccr.2010.02.027
Lejal N, Tarus B, Bouguyon E et al (2013) Structure-based discovery of the novel antiviral
properties of naproxen against the nucleoprotein of influenza a virus. Antimicrob. Agents
Chemother. 57:2231–2242. https://doi.org/10.1128/AAC.02335-12
Liu D, Hao K, Wang W et al (2017) Rv2629 overexpression delays mycobacterium smegmatis and
mycobacteria tuberculosis entry into log-phase and increases pathogenicity of mycobacterium
smegmatis in mice. Front. Microbiol. 8:2231. https://doi.org/10.3389/fmicb.2017.02231
3
Drug Repurposing in Biomedical Research: Benefits and Challenges
33